Publication Date:
1990-06-25
Description:
Lipoprotein-associated coagulation inhibitor (LACI) appears to inhibit tissue factor (TF)-induced blood coagulation by forming a quaternary inhibitory complex containing factor Xa, LACI, factor VIIa, and TF. A genetically engineered hybrid protein consisting of the light chain of factor Xa and the first Kunitz-type inhibitor domain of LACI is shown to directly inhibit the activity of the factor VIIa-TF catalytic complex. Unlike inhibition of factor VIIa-TF activity by native LACI, inhibition by the hybrid protein is not dependent on factor Xa. In an assay of TF-induced coagulation, 50% TF inhibition occurs with hybrid protein at 35 nanograms per milliliter, whereas LACI at 2.5 micrograms per milliliter is required for an equivalent effect. gamma-Carboxylation of glutamic acid residues in the factor Xa light chain portion of the hybrid protein is required for inhibitory activity, indicating that the first Kunitz-type domain of LACI alone is not sufficient for inhibition of factor VIIa-TF.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Girard, T J -- MacPhail, L A -- Likert, K M -- Novotny, W F -- Miletich, J P -- Broze, G J Jr -- New York, N.Y. -- Science. 1990 Jun 15;248(4961):1421-4.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Division of Hematology/Oncology, Jewish Hospital, Washington University Medical Center, St. Louis, MO 63110.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/1972598" target="_blank"〉PubMed〈/a〉
Keywords:
1-Carboxyglutamic Acid/metabolism
;
Amino Acid Sequence
;
Animals
;
Binding Sites
;
Calcium/metabolism
;
Cell Line
;
Cloning, Molecular
;
Factor VII/antagonists & inhibitors/metabolism/*pharmacology
;
Factor VIIa/*antagonists & inhibitors/metabolism
;
Factor Xa/metabolism/*pharmacology
;
Fibroblasts/metabolism
;
Glutamates/metabolism
;
Glutamic Acid
;
Lipoproteins/metabolism/*pharmacology
;
Mice
;
Molecular Sequence Data
;
Papillomaviridae
;
Protease Inhibitors/*pharmacology
;
Protein Sorting Signals
;
Recombinant Fusion Proteins/*pharmacology
;
Thromboplastin/antagonists & inhibitors/metabolism/*pharmacology
;
Transfection
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink